Skip to main content
NCBI home page
The Ochsner Journal logoLink to The Ochsner Journal
. 2003 Spring;5(2):57–62.

RECENT PUBLICATIONS BY OCHSNER AUTHORS

PMCID: PMC3124943  PMID: 21765756

References

  1. Akhund L., Quinet R. J., Ishaq S. Celecoxib-related renal papillary necrosis. Archives of Internal Medicine. 2003;163:114–115. doi: 10.1001/archinte.163.1.114. [DOI] [PubMed] [Google Scholar]
  2. Andersson H. C., Krousel-Wood M. A., Jackson K. E., Lubin I. M. Medical genetic test reporting in molecular cystic fibrosis (deltaF508) and factor V Leiden in North American laboratories. Genetics in Medicine. 2002;4:324–327. doi: 10.1097/00125817-200209000-00002. [DOI] [PubMed] [Google Scholar]
  3. Appell R., Winters J. Periurethral injectables. 2002:427–430. In: Ransom S, Dombrowski M, Evans M, Ginsberg K (eds). Contemporary Therapy in Obstetrics and Gynecology. Philadelphia: W. B. Saunders. [Google Scholar]
  4. Baumgarten K. K., Pankey G. A. Multidrug-resistant bacterial nosocomial infections: Strategies to prevent emergence. 2002;14(4):1–8. In: Pankey GA (ed). Ochsner Clinic Reports on Serious Hospital Infections. Newtown, PA: Associates in Medical Marketing, Co., Inc. pages. [Google Scholar]
  5. Blazek J. Pregnancy after transplantation. 2003:279–288. In: Cupples SA, Ohler L (eds). Transplantation Nursing Secrets. Philadelphia: Hanley & Belfus, Inc. [Google Scholar]
  6. Block G., Uribarri J., Coladonato J. A., Fan S. L., Cunningham J., Nolan C. R., Qunibi W. Y., Lindberg J. S. How should hyperphosphatemia be managed in dialysis patients? Seminars in Dialysis. 2002;15:315–328. doi: 10.1046/j.1525-139x.2002.00077_1.x. [DOI] [PubMed] [Google Scholar]
  7. Blonde L. New directions for type 2 diabetes mellitus management. American Journal of Managed Care. 2002;8:S437–440. (Suppl) [PubMed] [Google Scholar]
  8. Blonde L., Rosensock J., Mooradian A. D., Piper B. A., Henry D. Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy. Diabetes, Obesity & Metabolism. 2002;4:368–375. doi: 10.1046/j.1463-1326.2002.00229.x. [DOI] [PubMed] [Google Scholar]
  9. Bradford W. D., Kleit A. N., Krousel-Wood M. A., Re R. N. A two-part model of the cost of treating benign prostatic hyperplasia and the impact of innovation. Applied Economics. 2002;34:1291–1299. [Google Scholar]
  10. Carter K., Richardson W. Ochsner surgical case study. Ochsner Journal. 2002;4:254, 259. [Google Scholar]
  11. Chan A. W., Roffi M., Mukherjee D., Bajzer C. T., Abou-Chebl A., Ciezki J., Bhatt D. L., Ghaffari S., Yadav J. S. Carotid brachytherapy for in-stent restenosis. Catheterization and Cardiovascular Interventions. 2003;58:86–92. doi: 10.1002/ccd.10397. [DOI] [PubMed] [Google Scholar]
  12. Cohen D. J., Ramee S., Baim D. S., Sharma S., Carrozza J. P., Cosgrove R., Jones N., Berezin R. H., Cutlip D. E., Ho K. K., Kuntz R. E. Vein Graft AngioJet Study (VeGAS) 2 Investigators. Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial. American Heart Journal. 2001;142:648–656. doi: 10.1067/mhj.2001.117507. [DOI] [PubMed] [Google Scholar]
  13. Cole J. T., Kardinal C. G. Locally advanced and inflammatory breast cancer. 2002:579–595. In: Donegan WL, Spratt S (eds). Cancer of the Breast, 5th ed. Philadelphia: W. B. Saunders. [Google Scholar]
  14. Collins T. J., Subramanian R., White C. J. Gluteal arterial stenosis: An unusual cause of claudication. 2002:162–165. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  15. Conner M. S., Money S. R. Can claudication be improved with medication? Seminars in Vascular Surgery. 2002;15:237–244. doi: 10.1053/svas.2002.36259. [DOI] [PubMed] [Google Scholar]
  16. Conner M. S., III, Sternbergh W. C., III, Carter G., Tonnessen B. H., Yoselevitz M., Money S. R. Secondary procedures following endovascular aortic aneurysm repair. Journal of Vascular Surgery. 2002;36:1–5. doi: 10.1067/mva.2002.127966. [DOI] [PubMed] [Google Scholar]
  17. Cook J. L., Giardina J. F., Zhang Z., Re R. N. Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. Journal of Molecular and Cellular Cardiology. 2002;34:1525–1537. doi: 10.1006/jmcc.2002.2106. [DOI] [PubMed] [Google Scholar]
  18. Dalovisio J. R. Overview of lower respiratory tract infections: Diagnosis and treatment. Ochsner Journal. 2002;4:227–233. [PMC free article] [PubMed] [Google Scholar]
  19. Deininger P. L., Batzer M. A. Mammalian retroelements. Genome Research. 2002;12:1455–1465. doi: 10.1101/gr.282402. [DOI] [PubMed] [Google Scholar]
  20. Deitelzweig S. B., Vanscoy G. J., Niccolai C. S., Rihn T. L. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Annals of Pharmacotherapy. 2003;37:402–411. doi: 10.1345/aph.1C152. [DOI] [PubMed] [Google Scholar]
  21. Dumas-Hicks D. Immunosuppression. 2003:67–74. In: Cupples SA, Ohler L (eds). Transplantation Nursing Secrets. Philadelphia: Hanley & Belfus, Inc. [Google Scholar]
  22. Duplantier N., Finan M. A., Barbe T. Necessity of endometrial biopsy in women with enlarged uteri and a preoperative diagnosis of uterine leiomyomata. Journal of Reproductive Medicine. 2003;48:23–27. [PubMed] [Google Scholar]
  23. Durham H., Baumgarten K., Kemmerly S. What's your diagnosis? Breaking news and commentary. January 2003 Infectious Disease News. www.infectiousdiseasenews.com/200301/wyd.asp. [Google Scholar]
  24. Durham H., Pankey G. A. A report on vaccine availability administration protocols as of August 2002. Ochsner Journal. 2002;4:237–240. [PMC free article] [PubMed] [Google Scholar]
  25. Durham H. L., Fishman J., Garcia-Diaz J. B. A transplant patient with myocarditis and anemia. Infections in Medicine. 2002;19:446–451. 474. [Google Scholar]
  26. Eustis H. S., Guthrie M. E. Postnatal development. 2003:39–53. In: Wright KW, Spiegel PH (eds). Pediatric Ophthalmology and Strabismus, 2nd ed. New York: Springer Publishing. [Google Scholar]
  27. Felberg R. A. Brain attack. Ochsner Journal. 2003;5:44–46. [PMC free article] [PubMed] [Google Scholar]
  28. Felberg R. A. From the editor's desk. Ochsner Journal. 2003;5(1):2. [Google Scholar]
  29. Felberg R. A., Naideck A. The five Ps of acute ischemic stroke treatment: Parenchyma, pipes, perfusion, penumbra, and prevention of complications. Ochsner Journal. 2003;5:5–11. [PMC free article] [PubMed] [Google Scholar]
  30. Finley E. M. The crisscross tie-over tacking suture revisited. Dermatologic Surgery. 2003;29:281–283. doi: 10.1046/j.1524-4725.2003.29069.x. [DOI] [PubMed] [Google Scholar]
  31. Fox C. I., Sullivan M. A. Scanning the literature. Ochsner Journal. 2002;4:247–252. [PMC free article] [PubMed] [Google Scholar]
  32. Frohlich E. D. Annual Ochsner Graduate Medical Education house staff graduation speakers. Ochsner Journal. 2002;4:203. [PMC free article] [PubMed] [Google Scholar]
  33. Frohlich E. D. Hypertension research program at Ochsner: A program in translational research. Ochsner Journal. 2002;4:204–210. [PMC free article] [PubMed] [Google Scholar]
  34. Frohlich E. D., Robert P., Grant M. D. American Journal of Cardiology. 2003;91:646–648. doi: 10.1016/s0002-9149(02)03333-7. [DOI] [PubMed] [Google Scholar]
  35. Frohlich E. D. Treating hypertension—what are we to believe? New England Journal of Medicine. 2003;348:639–641. doi: 10.1056/NEJMe020179. [DOI] [PubMed] [Google Scholar]
  36. Frohlich E. D., Re R. N. Cardiac renin-angiotensin aldosterone system. Introduction. Journal of Molecular and Cellular Cardiology. 2002;34:1433. doi: 10.1006/jmcc.2002.2075. [DOI] [PubMed] [Google Scholar]
  37. Garcia-Diaz J. B., Baumgarten K. Phaeohyphomycotic infections in solid organ transplant patients. Seminars in Respiratory Infections. 2002;17:303–309. doi: 10.1053/srin.2002.36448. [DOI] [PubMed] [Google Scholar]
  38. Gauthier A. R., Jr, Winters J. C. Incontinent ileovesicostomy in the management of neurogenic bladder dysfunction. Neurourologic Urodynamics. 2003;22:142–146. doi: 10.1002/nau.10093. [DOI] [PubMed] [Google Scholar]
  39. Graham H. D., Quatela V., Sabini P. Rejuvenation of brow and midface. 2002:171–184. In: Papel ID (ed). Facial, Plastic and Reconstructive Surgery, 2nd ed. New York: Thieme Medical Publishers. [Google Scholar]
  40. Grossman E., Messerli F. H. Why _-blockers are not cardioprotective in elderly patients with hypertension. Current Cardiology Reports. 2002;4:468–473. doi: 10.1007/s11886-002-0108-3. [DOI] [PubMed] [Google Scholar]
  41. Hesse R. J. Refractive changes produced by capsule contraction after piggyback acrylic intraocular lens implantation. Journal of Cataract and Refractive Surgery. 2002;28:2229–2230. doi: 10.1016/s0886-3350(02)01278-6. [DOI] [PubMed] [Google Scholar]
  42. Ishaq S., Quinet R., Saba J. Phrenic nerve paralysis secondary to Lyme neuroborreliosis. Neurology. 2002;59:1810–1811. doi: 10.1212/01.wnl.0000035534.70975.c8. [DOI] [PubMed] [Google Scholar]
  43. Jenkins J. S. Bilateral (staged) vertebral artery stent placement. 2002:23–26. In: White CJ (ed). Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  44. Jenkins J. S. Bilateral vertebral artery stent placement. 2002:20–22. In: White CJ (ed). Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  45. Jenkins J. S., Subramanian R. Vertebral and intracranial artery angioplasty. Ochsner Journal. 2003;5:36–39. [PMC free article] [PubMed] [Google Scholar]
  46. Josephs K. A., van Gerpen M. W., Van Gerpen J. A. Adult onset Niemann-Pick disease type C presenting with psychosis. Journal of Neurology, Neurosurgery and Psychiatry. 2003;74:528–529. doi: 10.1136/jnnp.74.4.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Kalapura T., Lavie C. J., Ventura H. O. Idiopathic ventricular tachycardia in patients with structurally “normal” hearts. Emergency Medicine. 2002;34:21–24. [Google Scholar]
  48. Kalapura T., Lavie C. J., Ventura H. O. Treating ventricular tachycardia in normal hearts. Emergency Medicine. 2002;34:21–24. [Google Scholar]
  49. Kanakiriya S. K., Croatt A. J., Haggard J. J., Ingelfinger J. R., Tang S. S., Alam J., Nath K. A. Heme: A novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. American Journal of Physiology and Renal Physiology. 2003;284:F546–F554. doi: 10.1152/ajprenal.00298.2002. [DOI] [PubMed] [Google Scholar]
  50. Kardinal C. G. Hormonal and endocrine therapy of breast cancer. 2002:693–737. In: Donegan WL, Spratt S (eds). Cancer of the Breast, 5th ed. Philadelphia: W. B. Saunders. [Google Scholar]
  51. Khasani S., Ramee S. R., Felberg R. A. Ochsner Acute Stroke Intervention Service (OASIS). Therapy of postoperative stroke: report of intra-arterial thrombolysis of a hyperacute embolic stroke 5 days following CABG. Catheterization and Cardiovascular Interventions. 2001;54:339–341. doi: 10.1002/ccd.1295. [DOI] [PubMed] [Google Scholar]
  52. Kot J. B., Van Meter C. H. “Piggy-back” placement of supra-annular mitral valve. November 2001:3. Austin, TX: Sulzer Carbomedics. pp. [Google Scholar]
  53. Kuntz R. E., Baim D. S., Cohen D. J., Popma J. J., Carrozza J. P., Sharma S., McCormick D. J., Schmidt D. A., Lansky A. J., Ho K. K., Dandreo K. J., Setum C. M., Ramee S. R. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]) American Journal of Cardiology. 2002;89:326–330. doi: 10.1016/s0002-9149(01)02235-4. [DOI] [PubMed] [Google Scholar]
  54. Lanthier S., Riddick F. A., Jr, Gerber D. C. 1Q [3a]. What can be done to increase organ donation. Hospitals & Health Networks. 2002;76:28. [PubMed] [Google Scholar]
  55. Lavie C. J., Milani R. V. Multifactorial approach to the primary and secondary prevention of atherosclerosis. Ochsner Journal. 2003;5:12–17. [PMC free article] [PubMed] [Google Scholar]
  56. Leier C. V., Silver M. A., Massie B. M., Young J. B., Fowler M. B., Ventura H. O., Hershberger R. E. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1—the medical history. Congestive Heart Failure. 2001;7:245–249. doi: 10.1111/j.1527-5299.2001.00307.x. [DOI] [PubMed] [Google Scholar]
  57. Leier C. V., Silver M. A., Rich M. W., Eichhorn E. J., Fowler M. B., Giles T. D., Johnstone T. H., Lachmann J. S., Levine T. B., Armstrong P. W., Dec W. G., Jessup M., Howlett J., Hersberger R. E., Cohn J. N., Adams K. F., Jr, Colucci W. S., Warner-Stevenson L., Hosenpud J. D., Bristow M. R., Pina I., Baughman K. L., Binkley P. F., Ventura H. O. Nuggets, pearls and vignettes of master heart failure clinicians. Part 4—Treatment. Congestive Heart Failure. 2002;8:98–124. doi: 10.1111/j.1527-5299.2002.01169.x. [DOI] [PubMed] [Google Scholar]
  58. Leier C. V., Young J. B., Levine T. B., Pina I., Armstrong P. W., Fowler M. B., Warner-Stevenson L., Cohn J. N., O'Connell J. B., Bristow M. R., Nicklas J. M., Johnstone D. E., Howlett J., Ventura H. O., Giles T. D., Greenberg B. H., Chatterjee K., Bourge R. C., Yancy C. W., Gottlieb S. S. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2—the physical examination. Congestive Heart Failure. 2001;7:297–308. doi: 10.1111/j.1527-5299.2001.01167.x. [DOI] [PubMed] [Google Scholar]
  59. Lindberg J. Darbepoetin alfa: A new therapy for the management of anaemia associated with chronic kidney disease. Expert Opinion in Biological Therapy. 2002;2:977–984. doi: 10.1517/14712598.2.8.977. [DOI] [PubMed] [Google Scholar]
  60. Lindberg J. S., Moe S. M., Goodman W. G., Coburn J. W., Sprague S. M., Liu W., Blaisdell P. W., Brenner R. M., Turner S. A., Martin K. J. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney International. 2003;63:248–254. doi: 10.1046/j.1523-1755.2003.00720.x. [DOI] [PubMed] [Google Scholar]
  61. Loss G. E., Jr, Nair S., Blazek J., Farr G. H., Jr, Eason J. D. Liver transplantation for hepatocellular carcinoma: The Ochsner experience. Ochsner Journal. 2002;4:215–220. [PMC free article] [PubMed] [Google Scholar]
  62. Loyalka P., Smart F. W., Wiley J. M., Ventura H. O. Programas de insuficiencia cardiaca: Proveer su cuidado costo-benefico. Revista Argentina de Medicina. 2001;(2):51–56. III. [Google Scholar]
  63. Martin E. E., Jr Scanning the literature. Ochsner Journal. 2003;5:49–50. [PMC free article] [PubMed] [Google Scholar]
  64. Mehra M. R. Book review of Markers in Cardiology: Current and Future Clinical Applications. Congestive Heart Failure. 2002;8:191. Adams JE (ed). Armonk, NY: Futura Publishing Co., 2001, 272 pp. [Google Scholar]
  65. Mehra M. R., Uber P. A. Emergence of Laplace therapeutics: declaring an end to end-stage heart failure. Congestive Heart Failure. 2002;8:228–31. 234. doi: 10.1111/j.1527-5299.2002.01417.x. [DOI] [PubMed] [Google Scholar]
  66. Mehra M. R., Uber P. A., Park M. H., Scott R. L., Milani R. V. Does HDL-cholesterol level predict clinical outcome in advanced heart failure? Journal of Heart and Lung Transplantation. 2001;20:165. doi: 10.1016/s1053-2498(00)00301-6. [DOI] [PubMed] [Google Scholar]
  67. Mehra M. R., Uber P. A., Potluri S. Renin angiotensin aldos terone and adrenergic modulation in chronic heart failure: Contemporary concepts. American Journal of Medical Science. 2002;324:267–275. doi: 10.1097/00000441-200211000-00006. [DOI] [PubMed] [Google Scholar]
  68. Mehra M. R., Uber P. A., Scott R. L., Park M. H. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation. 2002;74:1568–1573. doi: 10.1097/00007890-200212150-00014. [DOI] [PubMed] [Google Scholar]
  69. Mehra M. R., Uber P. A., Vivekananthan K., Solis S., Scott R. L., Park M. H., Milani R. V., Lavie C. J. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. Journal of the American College of Cardiology. 2002;40:1609–1614. doi: 10.1016/s0735-1097(02)02340-9. [DOI] [PubMed] [Google Scholar]
  70. Mehra M. R., Ventura H. O., Uber P. A., Scott R. L., Park M. H. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox. Journal of Heart and Lung Transplantation. 2003;22:118–123. doi: 10.1016/s1053-2498(02)00492-8. [DOI] [PubMed] [Google Scholar]
  71. Messerli F. H. Evolution of calcium antagonists: Past, present, and future. Clinical Cardiology. 2003;26:II12–II16. doi: 10.1002/clc.4960261405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Messerli F. H. Hypertension. 2003:353–372. In: Rakel RE, Bope ET (eds). Conn's Current Therapy. Philadelphia: W.B. Saunders. [Google Scholar]
  73. Messerli F. H. The LIFE Study: The straw that should break the camel's back. European Heart Journal. 2003;24:487–489. doi: 10.1016/s0195-668x(02)00756-x. [DOI] [PubMed] [Google Scholar]
  74. Messerli F. H., Grossman E. Pedal edema—not all dihydropyridine calcium antagonists are created equal (editorial) American Journal of Hypertension. 2002;15:1019–1020. doi: 10.1016/s0895-7061(02)03087-x. [DOI] [PubMed] [Google Scholar]
  75. Messerli F. H., Grossman E., Fournier A. Losartan vs atenolol in prevention of stroke and cardiovascular disease (letter) Journal of the American Medical Association. 2003;289:700–701. doi: 10.1001/jama.289.6.700-b. [DOI] [PubMed] [Google Scholar]
  76. Messerli F. H., Mehra M. R. Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [life] study) American Journal of Cardiology. 2002;90:1133–1134. doi: 10.1016/s0002-9149(02)02782-0. [DOI] [PubMed] [Google Scholar]
  77. Messerli F. H., White W. B., Staessen J. A. If only cardiologists did properly measure blood pressure: Blood pressure recordings in daily practice and clinical trials. Journal of the American College of Cardiology. 2002;40:2201–2203. doi: 10.1016/s0735-1097(02)02607-4. [DOI] [PubMed] [Google Scholar]
  78. Milani R. V. In-hospital critical care: Incorporating risk reduction therapy into standing orders for discharge after MI. Cardiology Review. 2002;19:20–24. (Suppl) [Google Scholar]
  79. Milani R. V., Lavie C. J., Rubiano A. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects (letter) 2002 doi: 10.1161/01.cir.0000024254.18659.22. Circulation 106:e19; discussion e19. [DOI] [PubMed] [Google Scholar]
  80. Mitchell K. M., Beck D. E. Hidradenitis suppurativa. Surgical Clinics of North America. 2002;82:1187–1197. doi: 10.1016/s0039-6109(02)00060-9. [DOI] [PubMed] [Google Scholar]
  81. Montenegro S. H., Gilman R. H., Sheen P., Cama R., Caviedes L., Hopper T., Chambers R., Oberhelman R. A. Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clinical Infectious Diseases. 2003;36:16–23. doi: 10.1086/344900. [DOI] [PubMed] [Google Scholar]
  82. Moodie D. S. Adult congenital heart disease. Ochsner Journal. 2002;4:221–226. [PMC free article] [PubMed] [Google Scholar]
  83. Morshedi-Meibodi A., Uber P. A., Mehra M. R. Difficult cases in heart failure: Chemotherapy-related cardiomyopathy—all that glitters is not gold. Congestive Heart Failure. 2003;9:47–49. doi: 10.1111/j.1527-5299.2002.01902.x. [DOI] [PubMed] [Google Scholar]
  84. Nair S. Management of chronic viral hepatitis. Gastroenterology. 2002;123:2154–2155. [Google Scholar]
  85. Nair S., Chacko V., Arnold C., Diehl A. M. Hepatic ATP reserve and efficiency of replenishing: Comparison between obese and non-obese normal individuals. American Journal of Gastroenterology. 2003;98:466–470. doi: 10.1111/j.1572-0241.2003.07221.x. [DOI] [PubMed] [Google Scholar]
  86. Nair S., Eason J., Loss G. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Liver Transplantation. 2003;9:126–129. doi: 10.1053/jlts.2003.50026. [DOI] [PubMed] [Google Scholar]
  87. O'Very D. I. Stroke = brain attack. Ochsner Journal. 2003;5:58. [PMC free article] [PubMed] [Google Scholar]
  88. Odvina C. V., Preminger G. M., Lindberg J. S., Moe O. W., Pak C. Y. Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alka losis. Kidney International. 2003;63:240–247. doi: 10.1046/j.1523-1755.2003.00719.x. [DOI] [PubMed] [Google Scholar]
  89. Pandit-Bhalla M., Diethelm L., Ovella T., Sloop G. D., Valentine V. G. Idiopathic interstitial pneumonias: An update. Journal of Thoracic Imaging. 2003;18:1–13. doi: 10.1097/00005382-200301000-00001. [DOI] [PubMed] [Google Scholar]
  90. Pankey G. A. Ochsner Clinic Reports on Serious Hospital Infections. 2002;14(1):8. (editor) Newtown, PA: Associates in Medical Marketing, Co., Inc. pages. [Google Scholar]
  91. Park M. H., Scott R. L., Uber P. A., Harris B. C., Chambers R., Mehra M. R. Usefulness of B-type natriuretic pep tide levels in predicting hemodynamic perturba tions after heart transplantation despite preserved left ventricular systolic function. American Journal of Cardiology. 2002;90:1326–1329. doi: 10.1016/s0002-9149(02)02871-0. [DOI] [PubMed] [Google Scholar]
  92. Park M. H., Scott R. L., Uber P. A., Mehra M. R. Treatment of pulmonary hypertension: A promising new age. Catheterization and Cardiovascular Interventions. 2002;57:395–403. doi: 10.1002/ccd.10272. [DOI] [PubMed] [Google Scholar]
  93. Pathak R., Afaq A., Blonde L. Thiazolidinediones in the treatment of managed care patients with type 2 diabetes. American Journal of Managed Care. 2002;8:S483–S494. (Suppl) [PubMed] [Google Scholar]
  94. Perez M. G., Rodwig F. R., Jr Chronic relapsing thrombotic thrombocytopenic purpura in adult onset Still's disease. Southern Medical Journal. 2003;96:46–49. doi: 10.1097/01.SMJ.0000047763.56451.F0. [DOI] [PubMed] [Google Scholar]
  95. Performing procedures on the newly deceased. Academic Medicine. 2002;77:1212–1216. The Council on Ethical and Judicial Affairs of the American Medical Association (Rakatansky H, Riddick FA Jr, Morse LJ, et al) [PubMed] [Google Scholar]
  96. Perrillo R. From the editor's desk. Ochsner Journal. 2002;4(4):198–199. [PMC free article] [PubMed] [Google Scholar]
  97. Pinsky W. W. Another perfect storm. Ochsner Journal. 2003;5:3–4. [PMC free article] [PubMed] [Google Scholar]
  98. Plavec M. Ochsner medical case study. Ochsner Journal. 2002;4:253, 259. [PMC free article] [PubMed] [Google Scholar]
  99. Plavec O., Luftig R. B., Bautista A. P. Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics. Frontiers in Biosciences. 2002;7:e286–e300. doi: 10.2741/A924. [DOI] [PubMed] [Google Scholar]
  100. Prakash O., Nelson S. Alcohol and liver disease. Ochsner Journal. 2002;4:241–244. [PMC free article] [PubMed] [Google Scholar]
  101. Quinet R. J., Zakem J. M., McCain M. Localized versus systemic vasculitis: Diagnosis and management. Current Rheumatology Reports. 2003;5:93–99. doi: 10.1007/s11926-003-0036-2. [DOI] [PubMed] [Google Scholar]
  102. Quinlan P. Crossroads. Ochsner Journal. 2002;4:200–201. [PMC free article] [PubMed] [Google Scholar]
  103. Ramee S. R., White C. J. Superior mesenteric artery intervention (femoral approach) 2002:114–116. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  104. Re R. N. The implications of intracrine hormone action for physiology and medicine. American Journal of Physiology. Heart and Circulatory Physiology. 2003;284:H751–H757. doi: 10.1152/ajpheart.00935.2002. [DOI] [PubMed] [Google Scholar]
  105. Re R. N. The intracrine hypothesis and intracellular peptide hormone action. Bioessays. 2003;25:401–409. doi: 10.1002/bies.10248. [DOI] [PubMed] [Google Scholar]
  106. Richard-Davis G. Ovulation induction for in vitro fertilization: The role of gonadotropin-releasing hormone antagonist. Fertilization and Reproductive Medicine Clinics of North America. 2002;13:437–444. [Google Scholar]
  107. Riddick F. A. Promoting organ donations: Is it time to test new ideas? Medical Crossfire. 2002;4:34–35. [Google Scholar]
  108. Riddick F. A., Bovi A. Highlights of the Code of Medical Ethics of the American Medical Association. Sec E 5.00 Opinions on confidentiality, advertising and communications media relations. (Mar–Apr) 19–22, 2002 MetroDoctors. Journal of Hennepin and Ramsey Medical Societies. [Google Scholar]
  109. Riddick F. A., Morin K. Highlights of the Code of Medical Ethics of the American Medical Association. Sec E 2.00 Opinions on Social Policy Issues. (Sep–Oct) 18–19, 2001 MetroDoctors. Journal of Hennepin and Ramsey Medical Societies. [Google Scholar]
  110. Riddick F. A., Morin K. Highlights of the Code of Medical ethics of the American Medical Association, Sec E 3.00 Opinions on Interpersonal Relations. Sec E4.00 Opinions on hospital relations. (Jan–Feb) 20–21, 2002 MetroDoctors.Journal of Hennepin and Ramsey Medical Societies. [Google Scholar]
  111. Riddick F. A., Morin K. Highlights of the Code of Medical Ethics of the American Medical Society. Sec E 6.00 Opinions of fees and changes. (May–June) 21–23, 2002 MetroDoctors. Journal of Hennepin and Ramsey Medical Societies. [Google Scholar]
  112. Rietschel R. L., Mathias C. G., Fowler J. F., Jr, Pratt M., Taylor J. S., Sherertz E. F., Marks J. G., Jr, Belsito D. V., Storrs F. J., Maibach H. I., Fransway A. F., Deleo V. A. Relationship of occupation to contact dermatitis: Evaluation in patients tested from 1998 to 2000. American Journal of Contact Dermatitis. 2002;13:170–176. doi: 10.1053/ajcd.2002.36635. [DOI] [PubMed] [Google Scholar]
  113. Roehrborn C. G., Bruskewitz R., Nickel G. C., Glickman S., Cox C., Anderson R., Kandzari S., Herlihy R., Kornitzer G., Brown B. T., Holtgrewe H. L., Taylor A., Wang D., Waldstreicher J. Characterization of patients and ultimate outcomes. European Urology. 2000;37:528–536. doi: 10.1159/000020189. the PLESS Study Group (Fuselier HA, member): Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. [DOI] [PubMed] [Google Scholar]
  114. Rouchell A. M., Pounds R., Tierney J. G. Depression. 2002:307–338. In: Wise MG, Rundell JR (eds). The Textbook of Consultation-Liaison Psychiatry. Arlington, VA: The American Psychiatric Press. [Google Scholar]
  115. Roy-Engel A. M., Salem A. H., Oyeniran O. O., Deininger L., Hedges D. J., Kilroy G. E., Batzer M. A., Deininger P. L. Active Alu element “A-tails”: Size does matter. Genome Research. 2002;12:1333–1344. doi: 10.1101/gr.384802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Rundback J. H., Sacks D., Kent K. C., Cooper C., Jones D., Murphy T., Rosenfield K., White C. Guidelines for reporting of renal artery revascularization in clinical trials. Circulation. 2002;106:1572–1585. doi: 10.1161/01.cir.0000029805.87199.45. [DOI] [PubMed] [Google Scholar]
  117. Samal A. K., Ventura H. O., Berman A., Okereke C., Gilliland Y. E., Willis G. W. Myxosarcoma: a rare primary cardiac tumor. Journal of the Louisiana State Medical Society. 2002;154:308–312. [PubMed] [Google Scholar]
  118. Samal A. K., White C. J., Collins T. J. Subclavian vein thrombosis. 2002:66–67. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  119. Sangha S. S., Uber P. A., Park M. H., Scott R. L., Mehra M. R. Difficult cases in heart failure: the challenge of neurocognitive dysfunction in severe heart failure. Congestive Heart Failure. 2002;8:232–234. doi: 10.1111/j.1527-5299.2002.01078.x. [DOI] [PubMed] [Google Scholar]
  120. Silva J. A. Adjunctive abciximab for limb threatening ischemia. 2002:168–173. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  121. Silva J. A., White C. J. Percutaneous intervention of old degenerated saphenous vein grafts. International Journal of Cardiovascular Intervention. 2002;4:187–194. doi: 10.1080/14628840127767. [DOI] [PubMed] [Google Scholar]
  122. Silva J. A., White C. J., Ramee S. R., Collins T. J., Jenkins J. S., Ho K., Baim D. S., Carrozza J. P., Rinfret S., Setum C. M., Popma J. J., Kuntz R. E. Treatment of coronary stent thrombosis with rheolytic thrombectomy: Results from a multicenter experience. Catheterization and Cardiovascular Intervention. 2003;58:11–17. doi: 10.1002/ccd.10385. [DOI] [PubMed] [Google Scholar]
  123. Skibell B. C., Hesse R. J. Recurrent facial palsy occurring with metastatic thymic carcinoid and non-arteritic ischemic optic neuropathy. Ophthalmic Plastic and Reconstructive Surgery. 2003;19:164–165. doi: 10.1097/01.IOP.0000056025.65389.C3. [DOI] [PubMed] [Google Scholar]
  124. Slama M., Susic D., Frohlich E. D. Prevention of hypertension. Current Opinion in Cardiology. 2002;17:531–536. doi: 10.1097/00001573-200209000-00014. [DOI] [PubMed] [Google Scholar]
  125. Slama M., Susic D., Varagic J., Ahn J., Frohlich E. D. Echocardiographic measurement of cardiac output in rats. American Journal of Physiology. Heart and Circulatory Physiology. 2003;284:H691–H697. doi: 10.1152/ajpheart.00653.2002. [DOI] [PubMed] [Google Scholar]
  126. Sloan J. A., Bonner J. A., Hillman S. L., Allmer C., Shanahan T. G., Brooks B. J., Marks R. S., Vargas-Chanes D., Jett J. R. A quality-adjusted reanalysis of a phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer. International Journal of Radiation, Oncology, Biology and Physics. 2002;52:371–381. doi: 10.1016/s0360-3016(01)01819-3. [DOI] [PubMed] [Google Scholar]
  127. Sloan J. A., Sargent D. J., Lindman J., Allmer C., Vargas-Chanes D., Creagen E. T., Bonner J. A., O'Connell M. J., Dalton R. J., Rowland K. M., Brooks B. J., Laurie J. A. A new graphic for quality adjusted years (Q-TWiST) survival analysis: The Q-TWiST plot. Quality of Life Research. 2002;11:37–45. doi: 10.1023/a:1014401516011. [DOI] [PubMed] [Google Scholar]
  128. Smith J. The preliminary capsule endoscopy experience at Ochsner Clinic Foundation. Ochsner Journal. 2002;4:234–236. [PMC free article] [PubMed] [Google Scholar]
  129. Smith R. D. Extracranial-intracranial bypass in cerebral ischemia. Ochsner Journal. 2003;5:31–35. [PMC free article] [PubMed] [Google Scholar]
  130. Sternbergh W. C., III, Money S. R. Influence of preoperative risk factors on outcome after carotid endarterectomy. Ochsner Journal. 2003;5:24–30. [PMC free article] [PubMed] [Google Scholar]
  131. Stewart D., Killeen E., Naquin R., Alam S., Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. Journal of Biological Chemistry. 2003;278:2396–2402. doi: 10.1074/jbc.M209195200. [DOI] [PubMed] [Google Scholar]
  132. Stone G. W., Rogers C., Ramee S., White C., Kuntz R. E., Popma J. J., George J., Almany S., Bailey S. Distal filter protection during saphenous vein graft stenting. Technical and clinical correlates of efficacy. Journal of the American College of Cardiology. 2002;40:1882–1888. doi: 10.1016/s0735-1097(02)02129-0. [DOI] [PubMed] [Google Scholar]
  133. Strub R. L. Vascular dementia. Ochsner Journal. 2003;5:40–43. [PMC free article] [PubMed] [Google Scholar]
  134. Suranyi M. G., Lindberg J. S., Navarro J., Elias C., Brenner R. M., Walker R. Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease. American Journal of Nephrology. 2003;23:106–111. doi: 10.1159/000068041. [DOI] [PubMed] [Google Scholar]
  135. Tenery R., Rakatansky H., Riddick F. A., Jr Surgical “placebo” controls. Annals of Surgery. 2002;235:303–307. doi: 10.1097/00000658-200202000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Toda K., Mackenzie K., Mehra M. R., DiCorte C. J., Davis J. E., McFadden P. M., Ochsner J. L., White C., Van Meter C. H., Jr Revascularization in severe ventricular dysfunction (15%£LVEF£30%): A comparison of bypass surgery and percutaneous intervention. Annals of Thoracic Surgery. 2002;74:2082–2087. doi: 10.1016/s0003-4975(02)04120-6. [DOI] [PubMed] [Google Scholar]
  137. Tonnessen B. H., Conners M. S., Sternbergh W. C., Carter G., Yoselevitz M., Money S. R. Mid-term results of patients undergoing endovascular aortic aneurysm repair. American Journal of Surgery. 2002;184:561–566. doi: 10.1016/s0002-9610(02)01053-x. [DOI] [PubMed] [Google Scholar]
  138. Uber P. A., Mehra M. R., Park M. H., Ventura H., Scott R. L. Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation? Journal of Heart and Lung Transplantation. 2001;20:164–165. doi: 10.1016/s1053-2498(00)00300-4. [DOI] [PubMed] [Google Scholar]
  139. Van Gerpen J. A., Ahlskog J. E. Selegiline and mortality in subjects with Parkinson's disease: A longitudinal community study (letter) Neurology. 57:368–9. doi: 10.1212/wnl.57.2.368-a. author reply 369–70, 2001. [DOI] [PubMed] [Google Scholar]
  140. Van Gerpen J. A., McKinley K. L. Leuprolide-induced myopathy (letter) Journal of the American Geriatrics Society. 2002;50:1746. doi: 10.1046/j.1532-5415.2002.50474.x. [DOI] [PubMed] [Google Scholar]
  141. Varagic J., Frohlich E. D. Local cardiac renin-angiotensin system: Hypertension and cardiac failure. Journal of Molecular and Cellular Cardiology. 2002;34:1435–1442. doi: 10.1006/jmcc.2002.2075. [DOI] [PubMed] [Google Scholar]
  142. Vassilev T., Scharfenberg J., Garcia-Diaz J. Penile lesions in a heart transplant patient. Infections in Medicine. 2003;20:84. [Google Scholar]
  143. Ventura H. O. The Copernicus journey. American Journal of Cardiology. 2002;89:783–784. [Google Scholar]
  144. Ventura H. O., Edward D., Frohlich M. D. A conversation about hypertension: From bedside to bench and return. Congestive Heart Failure. 2002;8:321–330. doi: 10.1111/j.1527-5299.2002.01810.x. [DOI] [PubMed] [Google Scholar]
  145. Ventura H. O. Sir Christiaan Barnard: A personal reflection. American Journal of Cardiology. 2002;89:782–783. [Google Scholar]
  146. Ventura H. O., Randrup E. Curtis Tyrone. Ochsner Journal. 2002;4:245–246. [PMC free article] [PubMed] [Google Scholar]
  147. Ventura H. O., Randrup E., LeJeune M. D. Ochsner Journal. 2003;5:47–48. Francis Earnest (“Duke”) [PMC free article] [PubMed] [Google Scholar]
  148. Vivekananthan K., Kalapura T., Mehra M. R., Lavie C. J., Milani R. V., Scott R. L., Park M. H. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. American Journal of Cardiology. 2002;90:517–520. doi: 10.1016/s0002-9149(02)02525-0. [DOI] [PubMed] [Google Scholar]
  149. Walsh M. E., Rice K. Venous thrombosis and pulmonary embolism. 1999:342–363. In: Fahey VA (ed). Vascular Nursing, 3rd ed. Philadelphia: W. B. Saunders. [Google Scholar]
  150. West N., Roy-Engel A. M., Imataka H., Sonenberg N., Deininger P. Shared protein components of SINE RNPs. Journal of Molecular Biology. 2002;321:423–432. doi: 10.1016/s0022-2836(02)00542-9. [DOI] [PubMed] [Google Scholar]
  151. White C. J., Ramee S. R., Collins T. J., Jenkins J. S., Silva J. A., Chan A. W., Reily J. P., Felberg, McKinley K. L. Carotid stents to prevent stroke: A nonsurgical option. Ochsner Journal. 2003;5:18–23. Qunitana (sic) HA. [PMC free article] [PubMed] [Google Scholar]
  152. White C., Ramee S., Jenkins J. S., Collins T. 2001:103. Quick Guide to Peripheral Vascular Stenting. Royal Oak, MI: Physicians' Press. pages. [PMC free article] [PubMed] [Google Scholar]
  153. White C. J. Carotid stent placement with abciximab. 2002:3–5. In: White CJ (ed). Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  154. White C. J. Femoro-popliteal artery angioplasty. 2002:166–167. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  155. White C. J. 2002:219. (editor): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. pages. [Google Scholar]
  156. White C. J. Preface. 2002:xv. In: White CJ (ed). Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  157. White C. J., Ramee S. R. Celiac artery intervention. 2002:112–113. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  158. Whitlow P. L., Bass T. A., Kipperman R. M., Sharaf B. L., Ho K. K., Cutlip D. E., Zhang Y., Kuntz R. E., Williams D. O., Lasorda D. M., Moses J. W., Cowley M. J., Eccleston D. S., Horrigan M. C., Bersin R. M., Ramee S. R., Feldman T. Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS) American Journal of Cardiology. 2001;87:699–705. doi: 10.1016/s0002-9149(00)01486-7. [DOI] [PubMed] [Google Scholar]
  159. Winters J., Dmochowski R. A Woman With Urinary Frequency. American Urological Association Patient Management Program CD ROM Series, Volume 5 #3, 2002, Toronto, Canada, B. C. Decker, Co. [Google Scholar]
  160. Wong C-K., Ganz P., Miller L., Kobashigawa J., Schwarzkopf A., Valantine, von Kaeper H., Wilensky R., Ventura H., Yeung A. C. Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: A multicenter prospective intravascular ultrasound study. 2001:385–392. doi: 10.1016/s1053-2498(00)00230-8. Journal of Heart and Lung Transplantation. [DOI] [PubMed] [Google Scholar]
  161. Wynn M., Witzig R., Garcia-Diaz J. B. An elderly man with CD4 lymphopenia. Infectious Medicine. 2002;19:502–506. [Google Scholar]
  162. Wynn M. D., McLellan S. L. F., Steele R. W., Kemmerly S. A. A case of progressive dementia. Infections in Medicine. 2003;20:85–88. [Google Scholar]
  163. York J. W., Money S. R. Endovascular abdominal aortic aneurysm repair with suprarenal aortic fixation. 2002:84–89. In: White CJ (ed): Fifty Cases of Peripheral Vascular Interventions. London: Martin Dunitz Ltd. [Google Scholar]
  164. Zaki A. M., Kasem H. H., Bakhoum S., Mokhtar M., El Nagar W., White C. J., El Guindy M. Comparison of early results of percutaneous metallic mitral commis surotome with Inoue balloon technique in patients with high mitral echocardiographic scores. Catheterization and Cardiovascular Interventions. 2002;57:312–317. doi: 10.1002/ccd.10312. [DOI] [PubMed] [Google Scholar]

Articles from The Ochsner Journal are provided here courtesy of Ochsner Clinic Foundation

RESOURCES